デフォルト表紙
市場調査レポート
商品コード
1667811

肥厚性・ケロイド性瘢痕治療の世界市場レポート 2025年

Hypertrophic And Keloid Scar Treatment Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
肥厚性・ケロイド性瘢痕治療の世界市場レポート 2025年
出版日: 2025年02月28日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

肥厚性・ケロイド性瘢痕治療の市場規模は今後数年で急成長が見込まれます。2029年の年間平均成長率(CAGR)は10.1%で、125億1,000万米ドルに成長します。予測期間の成長は、低侵襲的介入の台頭、瘢痕修正技術の進歩、併用療法への関心の高まり、認知度の向上と早期介入、世界の美容動向に起因しています。予測期間における主な動向としては、新たな注射療法、相乗効果を狙った併用療法、患者中心のアプローチ、瘢痕評価技術、経過観察や診察のための遠隔医療などが挙げられます。

肥厚性・ケロイド性瘢痕治療市場は、交通事故と熱傷症例の増加により成長が見込まれます。少なくとも1台の車両と個人が関与する交通事故では、その結果生じる瘢痕に対処するための注意と効果的な治療が必要となります。肥厚性瘢痕やケロイド瘢痕の治療は、瘢痕の高さや硬さを下げる上で重要な役割を果たし、市場の拡大に寄与しています。例えば、2022年8月の米国道路交通安全局(National Highway Traffic Safety Administration)の統計によると、2022年1~3月の自動車交通事故死亡者数は2021年の同時期と比較して7%近く増加しており、このようなケースにおける瘢痕治療の必要性が浮き彫りになっています。

美容施術の人気の高まりが、今後の肥厚性・ケロイド性瘢痕治療市場の成長を牽引すると予測されます。美容施術とは、個人の外観を向上させ、さまざまな美容上の悩みに対処することを目的とした、非侵襲的または低侵襲の美容治療を指します。肥厚性瘢痕やケロイド瘢痕の治療は、盛り上がった瘢痕の見た目を軽減・改善し、より滑らかで魅力的な仕上がりをもたらすため、これらの施術に不可欠です。例えば、2024年6月、米国を拠点とする形成外科医のための組織である国際美容形成外科学会(ISAPS)は、2023年には脂肪吸引が最も一般的な外科手術として、220万件以上の手術が行われ、2022年からのリードを維持したと報告しました。豊胸手術と眼瞼手術がこれに僅差で続き、いずれも顕著な伸びを示しています。眼瞼手術は24%増の170万件以上に達し、鼻形成術は21.6%増の110万件に達し、目覚ましい増加を見せました。このように、美容整形手術の増加が肥厚性・ケロイド性瘢痕治療市場を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の肥厚性・ケロイド性瘢痕治療市場のPESTEL分析(政治、社会、技術、環境、法的要因、促進要因、抑制要因)
  • 最終用途産業の分析
  • 世界の肥厚性・ケロイド性瘢痕治療市場:成長率分析
  • 世界の肥厚性・ケロイド性瘢痕治療市場の実績:規模と成長、2019~2024年
  • 世界の肥厚性・ケロイド性瘢痕治療市場の予測:規模と成長、2024~2029年、2034年
  • 世界の肥厚性・ケロイド性瘢痕治療総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の肥厚性・ケロイド性瘢痕治療市場:治療別、実績と予測、2019~2024年、2024~2029年、2034年
  • 凍結療法
  • 外科的切除
  • 圧迫包帯
  • 病変内5-フルオロウラシル
  • 表面X線
  • 病変内コルチコステロイド注射
  • その他
  • 世界の肥厚性・ケロイド性瘢痕治療市場:製品別、実績と予測、2019~2024年、2024~2029年、2034年
  • 局所用製品
  • レーザー製品
  • 注射剤
  • その他
  • 世界の肥厚性・ケロイド性瘢痕治療市場:瘢痕別、実績と予測、2019~2024年、2024~2029年、2034年
  • 肥厚性瘢痕
  • ケロイド性瘢痕
  • 世界の肥厚性・ケロイド性瘢痕治療市場:最終用途別、実績と予測、2019~2024年、2024~2029年、2034年
  • 病院
  • クリニック
  • その他
  • 世界の肥厚性・ケロイド性瘢痕治療市場:凍結療法のサブセグメンテーション:タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 液体窒素凍結療法
  • 病変内凍結療法
  • 世界の肥厚性・ケロイド性瘢痕治療市場:外科的切除のサブセグメンテーション:タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 単純切除
  • 皮膚移植を伴う切除
  • 世界の肥厚性・ケロイド性瘢痕治療市場:圧迫包帯のサブセグメンテーション:タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 弾性包帯圧迫包帯
  • シリコンゲル圧迫包帯
  • 世界の肥厚性・ケロイド性瘢痕治療市場:病変内5-フルオロウラシルのサブセグメンテーション:タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 単独5-FU治療
  • コルチコステロイドとの併用
  • 世界の肥厚性・ケロイド性瘢痕治療市場:表面X線のサブセグメンテーション:タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 低線量X線治療
  • X線と他治療法の併用
  • 世界の肥厚性・ケロイド性瘢痕治療市場:病変内コルチコステロイド注射のサブセグメンテーション:タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • トリアムシノロンアセトニド注射剤
  • 5-フルオロウラシルとの併用
  • 世界の肥厚性・ケロイド性瘢痕治療市場:その他のサブセグメンテーション:タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • レーザー治療
  • 放射線治療
  • インターフェロン療法

第7章 地域別・国別分析

  • 世界の肥厚性・ケロイド性瘢痕治療市場:地域別、実績と予測、2019~2024年、2024~2029年、2034年
  • 世界の肥厚性・ケロイド性瘢痕治療市場:国別、実績と予測、2019~2024年、2024~2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 肥厚性・ケロイド性瘢痕治療市場:競合情勢
  • 肥厚性・ケロイド性瘢痕治療市場:企業プロファイル
    • Smith & Nephew plc Overview, Products and Services, Strategy and Financial Analysis
    • Merz Pharmaceutical LLC Overview, Products and Services, Strategy and Financial Analysis
    • Lumenis Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Enaltus LLC Overview, Products and Services, Strategy and Financial Analysis
    • Sonoma Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Molnlycke Health Care AB
  • Suneva Medical Inc.
  • Pacific World Corporation
  • Perrigo Company plc
  • Cynosure Inc.
  • Alliance Pharma plc
  • Newmedical Technology Inc.
  • HRA Pharma
  • Scar Heal Inc.
  • McKesson Medical Surgical Inc.
  • Johnson & Johnson Private Limited
  • Medtronic plc
  • 3M Company
  • Sinclair Pharma plc
  • Avita Medical

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 肥厚性・ケロイド性瘢痕治療市場2029年:新たな機会を提供する国
  • 肥厚性・ケロイド性瘢痕治療市場2029年:新たな機会を提供するセグメント
  • 肥厚性・ケロイド性瘢痕治療市場2029年:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r24216

Hypertrophic and keloid scar treatment involves addressing scars that either remain within the boundaries of the original wound (hypertrophic) or extend beyond those boundaries and do not regress (keloids). Hypertrophic scars are contained within the area of the initial injury, while keloids spread outside the boundaries of the initial damage.

The main treatments for hypertrophic and keloid scars include cryotherapy, surgical excision, pressure dressings, intralesional 5-fluorouracil, superficial X-ray, intralesional corticosteroid injection, and others. Cryotherapy is a medical procedure that uses extremely cold liquid or a cryoprobe to freeze and destroy abnormal tissue. It is employed to destroy the core of keloid scars while preserving surface-level cells and tissues. Various products, including topical products, laser products, injectables, and others, are used during treatment. The end-users of hypertrophic and keloid scar treatment include hospitals, clinics, and other healthcare facilities.

The hypertrophic and keloid scar treatment market research report is one of a series of new reports from The Business Research Company that provides hypertrophic and keloid scar treatment market statistics, including hypertrophic and keloid scar treatment industry global market size, regional shares, competitors with a hypertrophic and keloid scar treatment market share, detailed hypertrophic and keloid scar treatment market segments, market trends and opportunities, and any further data you may need to thrive in the hypertrophic and keloid scar treatment industry. This hypertrophic and keloid scar treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hypertrophic and keloid scar treatment market size has grown rapidly in recent years. It will grow from$7.72 billion in 2024 to $8.51 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to the rising incidence of hypertrophic and keloid scars, advancements in scar assessment, widespread adoption of topical treatments, surgical and invasive procedures, and patient demand for scar improvement

The hypertrophic and keloid scar treatment market size is expected to see rapid growth in the next few years. It will grow to $12.51 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to emerging minimally invasive interventions, advancements in scar revision techniques, growing interest in combination therapies, increasing awareness and early intervention, and global aesthetic trends. Major trends in the forecast period include emerging injectable therapies, combination therapies for synergistic effects, patient-centric approaches, scar assessment technologies, and telemedicine for follow-up and consultations.

The hypertrophic and keloid scar treatment market is anticipated to witness growth due to an increase in the number of road accidents and burn cases. Road accidents involving at least one vehicle and individuals necessitate attention and effective treatment to address resulting scars. Hypertrophic and keloid scar treatments play a crucial role in lowering the height and tightness of scars, contributing to the market's expansion. For instance, statistics from the National Highway Traffic Safety Administration in August 2022 revealed a nearly 7% increase in motor vehicle traffic accident fatalities during the first three months of 2022 compared to the same period in 2021, highlighting the need for scar treatments in such cases.

The increasing popularity of aesthetic procedures is anticipated to drive growth in the hypertrophic and keloid scar treatment market in the future. Aesthetic procedures refer to non-invasive or minimally invasive cosmetic treatments aimed at enhancing an individual's appearance and addressing various cosmetic concerns. Treatments for hypertrophic and keloid scars are integral to these procedures, as they help reduce and improve the appearance of raised scars, resulting in a smoother and more visually appealing outcome. For example, in June 2024, The International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization for plastic surgeons, reported that in 2023, liposuction remained the most common surgical procedure, with over 2.2 million procedures performed, sustaining its lead from 2022. Breast augmentation and eyelid surgery closely followed, both showing notable growth. Specifically, eyelid surgery saw a remarkable 24% increase, reaching more than 1.7 million procedures, while rhinoplasty rose by 21.6%, totaling 1.1 million procedures compared to the previous year. Thus, the rise in aesthetic procedures is propelling the hypertrophic and keloid scar treatment market.

Leading companies in the hypertrophic and keloid scar treatment market are strategically focusing on the development of clinically proven solutions, particularly those based on silicone, such as medical-grade silicone strips. These therapeutic products made from high-quality silicone are formulated to promote scar healing and reduction, offering an effective solution for various scar types. An example is Scar Erase, a UK-based company, which launched clinically tested silicone strips designed for scar healing and reduction, catering to hypertrophic, keloid, post-surgery, and stretch mark scars.

Major players in the market are also investing in advanced dermatological lines that leverage innovative technologies such as Microcyn technology. This technology accelerates wound healing, combats infections, and alleviates symptoms, providing clinically proven solutions. Sonoma Pharmaceuticals, a US-based pharmaceutical company, introduced a line of office dispensed products, including Regenacyn Plus, which is clinically proven to enhance the appearance of keloid and hypertrophic scars, offering relief from itch and pain while reducing infection risk.

In July 2022, Sinclair Pharma, a UK-based aesthetics company, completed the acquisition of Viora Ltd. The financial details of the acquisition remain undisclosed. This strategic move is expected to grant Sinclair access to Viora's portfolio of non-invasive and minimally invasive aesthetic devices. Additionally, the acquisition is anticipated to facilitate Sinclair's entry into the US market on a commercial scale. Viora Ltd., based in the US, specializes in providing medical aesthetic devices and solutions, including offerings related to scar and stretch mark revision, acne clearance, and various other aesthetic treatments.

Major companies operating in the hypertrophic and keloid scar treatment market include Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Stratpharma AG, Revitol Corporation Inc., Scarfade, Biodermis, Mederma, Silagen

North America was the largest region in the hypertrophic and keloid scar treatment market in 2024. Asia-pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hypertrophic and keloid scar treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hypertrophic and keloid scar treatment market consist of revenues earned by entities by providing occlusive dressings, compression therapy, intralesional corticosteroid injections, cryosurgery, excision, radiation therapy, laser therapy, interferon (IFN) therapy, doxorubicin, bleomycin, and verapamil. The market value includes the value of related goods sold by the service provider or included within the service offering. The hypertrophic and keloid scar treatment market also includes sales of skin camouflage, silicon gels, and skin needling. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hypertrophic And Keloid Scar Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hypertrophic and keloid scar treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hypertrophic and keloid scar treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hypertrophic and keloid scar treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Treatment: Cryotherapy; Surgical Excision; Pressure Dressings; Intralesional 5-Fluorouracil; Superficial X-Ray; Intralesional Corticosteroid Injection; Other Treatments
  • 2) By Products: Topical Products; Laser Products; Injectables; Other Products
  • 3) By Scar: Hypertrophic Scars; Keloid Scars
  • 4) By End-Use: Hospitals; Clinics; Other End-Users
  • Subsegments:
  • 1) By Cryotherapy: Liquid Nitrogen Cryotherapy; Intralesional Cryotherapy
  • 2) By Surgical Excision: Simple Excision; Excision With Skin Grafting
  • 3) By Pressure Dressings: Elastic Bandage Pressure Dressings; Silicone Gel Pressure Dressings
  • 4) By Intralesional 5-Fluorouracil: Standalone 5-FU Treatment; Combination With Corticosteroids
  • 5) By Superficial X-Ray: Low-Dose X-Ray Therapy; Combination X-Ray With Other Treatments
  • 6) By Intralesional Corticosteroid Injection: Triamcinolone Acetonide Injection; Combination With 5-Fluorouracil
  • 7) By Other Treatments: Laser Therapy; Radiotherapy; Interferon Therapy
  • Companies Mentioned: Smith & Nephew plc; Merz Pharmaceutical LLC; Lumenis Ltd.; Enaltus LLC; Sonoma Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hypertrophic And Keloid Scar Treatment Market Characteristics

3. Hypertrophic And Keloid Scar Treatment Market Trends And Strategies

4. Hypertrophic And Keloid Scar Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Hypertrophic And Keloid Scar Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hypertrophic And Keloid Scar Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hypertrophic And Keloid Scar Treatment Market Growth Rate Analysis
  • 5.4. Global Hypertrophic And Keloid Scar Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hypertrophic And Keloid Scar Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hypertrophic And Keloid Scar Treatment Total Addressable Market (TAM)

6. Hypertrophic And Keloid Scar Treatment Market Segmentation

  • 6.1. Global Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cryotherapy
  • Surgical Excision
  • Pressure Dressings
  • Intralesional 5-Fluorouracil
  • Superficial X-Ray
  • Intralesional Corticosteroid Injection
  • Other Treatments
  • 6.2. Global Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Topical Products
  • Laser Products
  • Injectables
  • Other Products
  • 6.3. Global Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hypertrophic Scars
  • Keloid Scars
  • 6.4. Global Hypertrophic And Keloid Scar Treatment Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Other End-Users
  • 6.5. Global Hypertrophic And Keloid Scar Treatment Market, Sub-Segmentation Of Cryotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Nitrogen Cryotherapy
  • Intralesional Cryotherapy
  • 6.6. Global Hypertrophic And Keloid Scar Treatment Market, Sub-Segmentation Of Surgical Excision, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Simple Excision
  • Excision With Skin Grafting
  • 6.7. Global Hypertrophic And Keloid Scar Treatment Market, Sub-Segmentation Of Pressure Dressings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Elastic Bandage Pressure Dressings
  • Silicone Gel Pressure Dressings
  • 6.8. Global Hypertrophic And Keloid Scar Treatment Market, Sub-Segmentation Of Intralesional 5-Fluorouracil, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standalone 5-FU Treatment
  • Combination With Corticosteroids
  • 6.9. Global Hypertrophic And Keloid Scar Treatment Market, Sub-Segmentation Of Superficial X-Ray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Low-Dose X-Ray Therapy
  • Combination X-Ray With Other Treatments
  • 6.10. Global Hypertrophic And Keloid Scar Treatment Market, Sub-Segmentation Of Intralesional Corticosteroid Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Triamcinolone Acetonide Injection
  • Combination With 5-Fluorouracil
  • 6.11. Global Hypertrophic And Keloid Scar Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laser Therapy
  • Radiotherapy
  • Interferon Therapy

7. Hypertrophic And Keloid Scar Treatment Market Regional And Country Analysis

  • 7.1. Global Hypertrophic And Keloid Scar Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hypertrophic And Keloid Scar Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hypertrophic And Keloid Scar Treatment Market

  • 8.1. Asia-Pacific Hypertrophic And Keloid Scar Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hypertrophic And Keloid Scar Treatment Market

  • 9.1. China Hypertrophic And Keloid Scar Treatment Market Overview
  • 9.2. China Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hypertrophic And Keloid Scar Treatment Market

  • 10.1. India Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hypertrophic And Keloid Scar Treatment Market

  • 11.1. Japan Hypertrophic And Keloid Scar Treatment Market Overview
  • 11.2. Japan Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hypertrophic And Keloid Scar Treatment Market

  • 12.1. Australia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hypertrophic And Keloid Scar Treatment Market

  • 13.1. Indonesia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hypertrophic And Keloid Scar Treatment Market

  • 14.1. South Korea Hypertrophic And Keloid Scar Treatment Market Overview
  • 14.2. South Korea Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hypertrophic And Keloid Scar Treatment Market

  • 15.1. Western Europe Hypertrophic And Keloid Scar Treatment Market Overview
  • 15.2. Western Europe Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hypertrophic And Keloid Scar Treatment Market

  • 16.1. UK Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hypertrophic And Keloid Scar Treatment Market

  • 17.1. Germany Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hypertrophic And Keloid Scar Treatment Market

  • 18.1. France Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hypertrophic And Keloid Scar Treatment Market

  • 19.1. Italy Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hypertrophic And Keloid Scar Treatment Market

  • 20.1. Spain Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hypertrophic And Keloid Scar Treatment Market

  • 21.1. Eastern Europe Hypertrophic And Keloid Scar Treatment Market Overview
  • 21.2. Eastern Europe Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hypertrophic And Keloid Scar Treatment Market

  • 22.1. Russia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hypertrophic And Keloid Scar Treatment Market

  • 23.1. North America Hypertrophic And Keloid Scar Treatment Market Overview
  • 23.2. North America Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hypertrophic And Keloid Scar Treatment Market

  • 24.1. USA Hypertrophic And Keloid Scar Treatment Market Overview
  • 24.2. USA Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hypertrophic And Keloid Scar Treatment Market

  • 25.1. Canada Hypertrophic And Keloid Scar Treatment Market Overview
  • 25.2. Canada Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hypertrophic And Keloid Scar Treatment Market

  • 26.1. South America Hypertrophic And Keloid Scar Treatment Market Overview
  • 26.2. South America Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hypertrophic And Keloid Scar Treatment Market

  • 27.1. Brazil Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hypertrophic And Keloid Scar Treatment Market

  • 28.1. Middle East Hypertrophic And Keloid Scar Treatment Market Overview
  • 28.2. Middle East Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hypertrophic And Keloid Scar Treatment Market

  • 29.1. Africa Hypertrophic And Keloid Scar Treatment Market Overview
  • 29.2. Africa Hypertrophic And Keloid Scar Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hypertrophic And Keloid Scar Treatment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hypertrophic And Keloid Scar Treatment Market, Segmentation By Scar, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hypertrophic And Keloid Scar Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Hypertrophic And Keloid Scar Treatment Market Competitive Landscape
  • 30.2. Hypertrophic And Keloid Scar Treatment Market Company Profiles
    • 30.2.1. Smith & Nephew plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merz Pharmaceutical LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Lumenis Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Enaltus LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sonoma Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Hypertrophic And Keloid Scar Treatment Market Other Major And Innovative Companies

  • 31.1. Molnlycke Health Care AB
  • 31.2. Suneva Medical Inc.
  • 31.3. Pacific World Corporation
  • 31.4. Perrigo Company plc
  • 31.5. Cynosure Inc.
  • 31.6. Alliance Pharma plc
  • 31.7. Newmedical Technology Inc.
  • 31.8. HRA Pharma
  • 31.9. Scar Heal Inc.
  • 31.10. McKesson Medical Surgical Inc.
  • 31.11. Johnson & Johnson Private Limited
  • 31.12. Medtronic plc
  • 31.13. 3M Company
  • 31.14. Sinclair Pharma plc
  • 31.15. Avita Medical

32. Global Hypertrophic And Keloid Scar Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hypertrophic And Keloid Scar Treatment Market

34. Recent Developments In The Hypertrophic And Keloid Scar Treatment Market

35. Hypertrophic And Keloid Scar Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Hypertrophic And Keloid Scar Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hypertrophic And Keloid Scar Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hypertrophic And Keloid Scar Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer